IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomas.

Saved in:
Bibliographic Details
Title: IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomas.
Authors: Arribas AJ; Università della Svizzera italiana, Institute of Oncology Research, Bellinzona, Switzerland., Cannas E; 1 Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland, Bellinzona, Switzerland., Sartori G; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland., Guidetti F; Università della Svizzera italiana, Istituto Oncologico di Ricerca., Cascione L; IOR - Institute of Oncology Research, Bellinzona, Switzerland., Napoli S; Institute of Oncology Research, Bellinzona, Switzerland., Forestieri G; Institute of Oncology Research, Bellinzona, Switzerland., Fuzio F; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland., Pesenti EDS; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland., Tarantelli C; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland., Spriano F; Institute of Oncology Research, Faculty of Biomedical Sciences, USI, bellinzona, Switzerland., Zucchetto A; Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy., Rossi FM; Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy., Bruscaggin A; Institute of Oncology Research, Bellinzona, Switzerland., Rinaldi A; Institute of Oncology Research, Bellinzona, Switzerland., Castro de Moura M; Josep Carreras Leukaemia Research Institute, Badalona, Spain., Jovic S; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland., Raimondi A; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland., Bordone Pittau R; IOSI Oncology Institute of Southern Switzerland., Terzi di Bergamo L; Institute of Oncology Research, Bellinzona, Switzerland., Ye X; Karolinska Institutet, Stockholm, Sweden., Stathis A; Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzoona, Switzerland., Ben-David Y; State Key Laboratory for Functions and Applications of Medicinal Plants, Guiyang, China., Pan-Hammarström Q; Karolinska Institutet, Stockholm, Sweden., Simonetta F; Geneva University Hospitals and University of Geneva, Genève, Switzerland., Stussi G; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland., Zucca E; Institute of Oncology Research, Bellinzona, Switzerland., Gattei V; Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy., Brown JR; Dana-Farber Cancer Institute, Boston, Massachusetts, United States., Esteller M; Josep Carreras Leukaemia Research Institute (IJC), Badalona, Spain., Rossi D; Institute of Oncology Research, Bellinzona, Switzerland., Bertoni F; Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
Source: Blood [Blood] 2026 May 29. Date of Electronic Publication: 2026 May 29.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1528-0020
DOI:10.1182/blood.2025029956